Endothelial growth factor receptor inhibition after radiotherapy

J Thorac Oncol. 2007 Jul;2(7):662. doi: 10.1097/JTO.0b013e318074de48.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Biomarkers, Tumor / antagonists & inhibitors
  • Biomarkers, Tumor / blood
  • Carcinoma, Non-Small-Cell Lung* / blood
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Carcinoma, Non-Small-Cell Lung* / radiotherapy
  • Follow-Up Studies
  • Gefitinib
  • Humans
  • Lung Neoplasms* / blood
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / radiotherapy
  • Male
  • Middle Aged
  • Quinazolines / therapeutic use*
  • Radiation Injuries / drug therapy
  • Radiation Injuries / pathology
  • Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors*
  • Receptors, Vascular Endothelial Growth Factor / blood
  • Skin / pathology
  • Skin / radiation effects

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Quinazolines
  • Receptors, Vascular Endothelial Growth Factor
  • Gefitinib